|
GB1524747A
(en)
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
EP0100172B1
(en)
|
1982-07-23 |
1987-08-12 |
Imperial Chemical Industries Plc |
Amide derivatives
|
|
GB8327256D0
(en)
|
1983-10-12 |
1983-11-16 |
Ici Plc |
Steroid derivatives
|
|
US5093330A
(en)
|
1987-06-15 |
1992-03-03 |
Ciba-Geigy Corporation |
Staurosporine derivatives substituted at methylamino nitrogen
|
|
US5010099A
(en)
|
1989-08-11 |
1991-04-23 |
Harbor Branch Oceanographic Institution, Inc. |
Discodermolide compounds, compositions containing same and method of preparation and use
|
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
WO1993019749A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
TW225528B
(enExample)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
|
SI0765308T1
(sl)
|
1994-06-15 |
2000-08-31 |
The Wellcome Foundation Limited |
Encimski inhibitorji
|
|
EP0817775B1
(en)
|
1995-03-30 |
2001-09-12 |
Pfizer Inc. |
Quinazoline derivatives
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US5843901A
(en)
|
1995-06-07 |
1998-12-01 |
Advanced Research & Technology Institute |
LHRH antagonist peptides
|
|
ATE212993T1
(de)
|
1995-07-06 |
2002-02-15 |
Novartis Erfind Verwalt Gmbh |
Pyrolopyrimidine und verfahren zu ihrer herstellung
|
|
US5760041A
(en)
|
1996-02-05 |
1998-06-02 |
American Cyanamid Company |
4-aminoquinazoline EGFR Inhibitors
|
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
|
EP0892789B2
(en)
|
1996-04-12 |
2009-11-18 |
Warner-Lambert Company LLC |
Irreversible inhibitors of tyrosine kinases
|
|
DE69734513T2
(de)
|
1996-06-24 |
2006-07-27 |
Pfizer Inc. |
Phenylamino-substituierte tricyclische derivate zur behandlung hyperproliferativer krankheiten
|
|
NZ334821A
(en)
|
1996-08-30 |
2000-12-22 |
Novartis Ag |
Method for producing epothilones
|
|
EP0938597B1
(en)
|
1996-09-06 |
2003-08-20 |
Obducat Aktiebolag |
Method for anisotropic etching of structures in conducting materials
|
|
AU4342997A
(en)
|
1996-09-13 |
1998-04-02 |
Sugen, Inc. |
Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders
|
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
|
HU229833B1
(en)
|
1996-11-18 |
2014-09-29 |
Biotechnolog Forschung Gmbh |
Epothilone d production process, and its use as cytostatic as well as phytosanitary agents
|
|
US6441186B1
(en)
|
1996-12-13 |
2002-08-27 |
The Scripps Research Institute |
Epothilone analogs
|
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
|
CO4940418A1
(es)
|
1997-07-18 |
2000-07-24 |
Novartis Ag |
Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
|
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
|
AU758526B2
(en)
|
1998-02-25 |
2003-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues therof
|
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
CN1152031C
(zh)
|
1998-08-11 |
2004-06-02 |
诺瓦提斯公司 |
具有血管生成抑制活性的异喹啉衍生物
|
|
CN100381566C
(zh)
|
1998-11-20 |
2008-04-16 |
科森生物科学公司 |
产生环氧噻酮及其衍生物的重组方法和材料
|
|
EP1175422A2
(en)
|
1999-05-04 |
2002-01-30 |
Ligand Pharmaceuticals Incorporated |
Tetracyclic progesterone receptor modulator compounds and methods
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
HUP0302302A2
(hu)
|
2000-09-29 |
2003-12-29 |
Glaxo Group Limited |
Morfolin-acetamid-származékok gyulladásos betegségek kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
|
KR100748386B1
(ko)
|
2000-11-07 |
2007-08-10 |
노파르티스 아게 |
단백질 키나제 ｃ 억제제로서의 인돌릴말레이미드 유도체
|
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
CA2432799C
(en)
|
2000-12-21 |
2008-08-19 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
EP2090571B1
(de)
|
2001-10-17 |
2012-05-16 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
ATE346058T1
(de)
|
2002-01-14 |
2006-12-15 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
|
|
EP1467730A4
(en)
|
2002-01-22 |
2010-03-10 |
Univ California |
Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
HRP20040887A2
(en)
|
2002-03-26 |
2005-04-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
PE20040079A1
(es)
|
2002-04-03 |
2004-04-19 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
CA2481320A1
(en)
|
2002-04-11 |
2003-10-23 |
Merck & Co., Inc. |
1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
AU2003281355A1
(en)
|
2002-07-08 |
2004-01-23 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
US6995181B2
(en)
|
2002-07-18 |
2006-02-07 |
Bristol-Myers Squibb Co. |
Modulators of the glucocorticoid receptor and method
|
|
JP2006504678A
(ja)
|
2002-08-21 |
2006-02-09 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
US20050245588A1
(en)
|
2002-09-20 |
2005-11-03 |
Amjad Ali |
Octahydro-2-h-naphtho[1,2-f]indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US20050014753A1
(en)
*
|
2003-04-04 |
2005-01-20 |
Irm Llc |
Novel compounds and compositions as protein kinase inhibitors
|
|
US8178671B2
(en)
|
2003-07-30 |
2012-05-15 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
|
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
|
ATE517882T1
(de)
|
2004-10-19 |
2011-08-15 |
Hoffmann La Roche |
Chinolinderivate
|
|
GB2420559B
(en)
|
2004-11-15 |
2008-08-06 |
Rigel Pharmaceuticals Inc |
Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
|
|
JP2008525422A
(ja)
|
2004-12-23 |
2008-07-17 |
ファイザー・プロダクツ・インク |
抗癌剤として有用な複素芳香族誘導体
|
|
WO2006074057A2
(en)
|
2004-12-30 |
2006-07-13 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
US8097630B2
(en)
|
2006-10-10 |
2012-01-17 |
Rigel Pharmaceuticals, Inc. |
Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors
|
|
GEP20125691B
(en)
|
2006-12-08 |
2012-11-26 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
WO2008118822A1
(en)
|
2007-03-23 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
BRPI0814432A2
(pt)
|
2007-07-17 |
2017-05-09 |
Rigel Pharmaceuticals Inc |
pirimidinadiaminas substituídas por amina cíclica como inibidores de pkc
|
|
WO2009080638A2
(en)
*
|
2007-12-20 |
2009-07-02 |
Cellzome Limited |
Sulfamides as zap-70 inhibitors
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
US8063058B2
(en)
|
2008-04-16 |
2011-11-22 |
Portola Pharmaceuticals, Inc. |
Inhibitors of syk and JAK protein kinases
|
|
WO2009145856A1
(en)
*
|
2008-04-16 |
2009-12-03 |
Portola Pharmaceuticals, Inc. |
2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
|
|
WO2009131687A2
(en)
*
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
NZ624345A
(en)
|
2008-06-27 |
2016-07-29 |
Celgene Avilomics Res Inc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8697694B2
(en)
|
2008-08-20 |
2014-04-15 |
Merck Sharp & Dohme Corp. |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
|
WO2010083241A2
(en)
|
2009-01-14 |
2010-07-22 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
|
|
US8377924B2
(en)
|
2009-01-21 |
2013-02-19 |
Rigel Pharmaceuticals Inc. |
Protein kinase C inhibitors and uses thereof
|
|
US8263632B2
(en)
|
2009-03-24 |
2012-09-11 |
Vertex Pharmaceuticals Incoporated |
Aminopyridine derivatives having Aurora A selective inhibitory action
|
|
US9908884B2
(en)
|
2009-05-05 |
2018-03-06 |
Dana-Farber Cancer Institute, Inc. |
EGFR inhibitors and methods of treating disorders
|
|
JP2012529522A
(ja)
|
2009-06-10 |
2012-11-22 |
アボット・ラボラトリーズ |
キナーゼ阻害剤としての２−（１ｈ−ピラゾール−４−イルアミノ）−ピリミジン
|
|
JP5802677B2
(ja)
|
2009-12-01 |
2015-10-28 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤およびその使用
|
|
JP6035238B2
(ja)
|
2010-07-21 |
2016-11-30 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
プロテインキナーゼｃ阻害剤およびその使用
|
|
WO2012059932A1
(en)
*
|
2010-11-01 |
2012-05-10 |
Aurigene Discovery Technologies Limited |
2, 4 -diaminopyrimidine derivatives as protein kinase inhibitors
|
|
PH12013500880A1
(en)
*
|
2010-11-10 |
2013-07-01 |
Hoffmann La Roche |
Pyrazole aminopyrimidine derivatives as lrrk2 modulators
|
|
US20150005281A1
(en)
|
2011-12-23 |
2015-01-01 |
Cellzome Limited |
Pyrimidine-2,4-diamine derivatives as kinase inhibitors
|
|
ES2655177T3
(es)
|
2012-02-17 |
2018-02-19 |
Abbvie Inc. |
Diaminopirimidinas útiles como inhibidores del virus respiratorio sincitial (VRS) humano
|
|
US9321763B2
(en)
|
2012-04-04 |
2016-04-26 |
Rigel Pharmaceuticals, Inc. |
Protein kinase C inhibitors and uses thereof
|
|
KR102091895B1
(ko)
*
|
2012-05-03 |
2020-04-14 |
제넨테크, 인크. |
파킨슨병의 치료에 사용하기 위한 lrrk2 조절제로서의 피라졸 아미노피리미딘 유도체
|
|
WO2014040555A1
(zh)
|
2012-09-12 |
2014-03-20 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的含氮杂芳环衍生物
|
|
EP2903617B1
(en)
|
2012-10-08 |
2019-01-30 |
Merck Sharp & Dohme Corp. |
Inhibitors of irak4 activity
|
|
BR112015011456A2
(pt)
|
2012-11-20 |
2017-07-11 |
Genentech Inc |
compostos de aminopirimidina como inibidores de egfr mutantes contendo t790m
|
|
CA2904610A1
(en)
|
2013-03-14 |
2014-09-25 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
|
WO2015039613A1
(zh)
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
EP3312164B1
(en)
*
|
2014-03-28 |
2020-12-09 |
Calitor Sciences, LLC |
Substituted heteroaryl compounds and methods of use
|